Iterum Therapeutics Plc (ITRM)
0.4694
+0.01
(+2.04%)
USD |
NASDAQ |
Dec 11, 16:00
0.4753
+0.01
(+1.26%)
After-Hours: 20:00
Iterum Therapeutics Shareholders Equity (Quarterly): -7.381M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp. Plc | 458.89M |
| Jazz Pharmaceuticals Plc | 3.959B |
| Prothena Corp. Plc | 294.99M |
| GH Research Plc | 291.40M |
| Mural Oncology Plc | 55.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.50M |
| Total Liabilities (Quarterly) | 39.88M |
| Debt to Equity Ratio | -4.570 |
| Current Ratio | 2.135 |
| Net Debt Paydown Yield | -8.10% |